• Phoenix PharmaLabs Inc

    • Pharmaceutical
    999 West 1500 South
    Building 600
    Woods Cross, UT 84087
    • About

      Phoenix has developed a novel class of poly-receptor morphinans with strong potential to replace the currently available opioid pain medicines that are euphoric, addictive and pose risk of death.

    • Whom to Contact

      • Timmy Chou
        Vice President, CFO